Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, Follicular × lucatumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Rituximab 39 Cyclophosphamide 38 fludarabine phosphate 21 Filgrastim 17 fludarabine 15 Lenalidomide 14 Bendamustine Hydrochloride 14 Peripheral Blood Stem Cell Transplantation 12 Etoposide 11 ibrutinib 10 Biopsy 10 Vincristine 9 Radiotherapy 9 Prednisone 9 Magnetic Resonance Spectroscopy 9 venetoclax 8 aldesleukin 8 Vorinostat 8 Specimen Handling 8 Cyclosporine 8 Bortezomib 8 obinutuzumab 7 Paclitaxel 7 Cytarabine 7 tanespimycin 6 pembrolizumab 6 Methylprednisolone 6 Melphalan 6 Gemcitabine 6 tazemetostat 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01275209 2020-12-08

LIFT

Novartis

Phase 1 Completed

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡